men's health newsletter

No.02/2008

ISMH International Society for Men's Health

International Men's Health Week 2008, 9-15 June 2008

International Men's health week takes place each year in the week leading up to father's day in many countries worldwide. The event aims to inrease awareness of general male health issues and to encourage inter- and intra-national institutions and organisations to provide better care for the health issues affecting men.

Each year the week focuses on a different theme relevant to men's health. This year, for example focus on the theme of men and the workplace. (see also journal of men's health).

Find more an overview of European activities at emhf.org

journal of men's health jmh

Vol. 5, Issue II, June 2008 - comming soon

Workplace and Occupational Health

• Editorial:            Brave, New World of Work - Flexible but also Healthier?
• Review:             Men's Health and the Workplace
• Original Article:   Targeting Men's Weight in the Workplace

more info at jmhjournal.org

Most recent issues in men's health & gender medicine

Exeptiopnal Longevity in Men Background 

Prospective data on nongenetic determinants of exceptional longevity are limited, and information on long-lived men and their functional status is particularly sparse. The authors examined modifiable factors associated with a life span of 90 or more years and late-life function in men. In this prospective cohort study of 2357 healthy men (mean age, 72 years) within the Physicians' Health Study (1981-2006), biological and lifestyle factors and comorbid conditions were assessed by self-report with baseline and annual questionnaires. Mortality and incidence of major diseases were confirmed by medical record review. Late-life function was assessed 16 years after baseline by the Medical Outcomes Study 36-Item Short-Form Health Survey.                                              

Read more at Archives of Internal Medicine

Treatment of Symptomatic Androgen Deficiency

Treatment patterns for androgen deficiency were estimated in a population-based random sample of 1486 community-dwelling men. Untreated androgen deficiency was defined using total and free testosterone thresholds (< 300 ng/dL and < 5 ng/dL, respectively) and symptoms, whereas a treated case was defined as anyone receiving testosterone therapy. The authors found that under their assumptions, the majority of men (87.8%) were not receiving treatment despite apparently adequate access to care.                                      

Read more at Archives of Internal Medicine

Screening for Osteoporosis in Men: A Clinical Practice Guideline from the American College of Physicians

The American College of Physicians developed this guideline to present the available evidence on risk factors and screening tests for osteoporosis in men.                                                                                                      

Read more at Annals of Internal Medicine

Recreational Use of PDE5 Inhibitors by Young Healthy Men: 

In recent years, recreational use of phosphodiesterase type 5 (PDE5) inhibitors has become popular as a sexual enhancement aid among some men without erectile dysfunction (ED) and even among women. The aim of the present study, therefore, was to investigate the recreational use of PDE5 among young and healthy men.        

Read more at Journal of Sexual Medicine

To unsubscribe the ISMH men's health newsletter, simply click here or send a email to nl-unsubscribe@ismh.org. Copyright © 2007 ISMH. All rights reserved. Imprint